Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
In this article we review the pharmacology and design of ADCs, as well as we describe the results of different studies evaluating ADCs in lung cancer directed to several targets including HER2, HER3, TROP2, MET, CEACAM5 and DLL3
LV, SSS, SR, CL, KLF, PLP and EL revised the article
Clinical trial results and real-world use paint a consistent side effect profile, the majority of which is mild and easily managed
In hepatocytes, SREBP2 activation increased HMGCR transcription, but ALC reverses this trend
What Drives Launch Pricing for Obesity Drugs Efficacy advantage
Fertil Steril 2003;79:292-300
US$ 24.11
US$ 25.76
US$ 24.88
US$ 27.83
US$ 22.00
US$ 29.88
US$ 24.56
US$ 22.03
